Drug Discovery

Biocon research arm Syngene International makes strong debut on bourses, up 26%

Syngene stock got listed at Rs 295 on NSE, up 18 percent over its issue price of Rs 250

Meet Eve: A 'robotic scientist' who makes drug discovery faster

An artificially-intelligent 'robot scientist' has discovered that a compound shown to have anti-cancer properties can also be used in the fight against malaria, UK researchers say.